Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

28.60
Delayed Data
As of Jul 29
 +0.75 / +2.69%
Today’s Change
20.07
Today|||52-Week Range
39.17
+1.10%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close27.85
Today’s open27.86
Day’s range27.78 - 29.03
Volume231,311
Average volume (3 months)288,852
Market cap$936.8M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+66.07%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio119.2
Price/Sales11.37
Price/Book7.48

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Internatio...-0.70-3.86%
FWPForward Pharma A/S+0.46+2.35%
CLLSCellectis SA+0.27+1.03%
ADROAduro Biotech Inc-0.24-1.61%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs